Aducanumab for Alzheimer’s disease: effectiveness and value; draft evidence report [Internet] - Lin, GA; Whittington, MD; Synnott, PG; McKenna, A; Campbell, J; Pearson, SD (Institute for Clinical and Economic Review, 2021)
2022 Mar 3 Available from: